SOPs for Lyophilized Products

The purpose of this SOP is to outline the procedures for enhancing the solubility of active ingredients in lyophilized formulations using various techniques such as pH adjustment, use of solubilizers, and complexation.
Click to read the full article.

This SOP outlines the procedures for the preparation of liposomal formulations for lyophilization, ensuring that the liposomes maintain their structural integrity and function during the lyophilization process and subsequent reconstitution.
Click to read the full article.

This SOP outlines the procedures for selecting and incorporating excipients in lyophilized formulations to ensure product stability, efficacy, and shelf life.
Click to read the full article.

This SOP outlines the procedure for the preparation of monoclonal antibody (mAb) formulations intended for lyophilization, ensuring that the mAbs maintain stability, efficacy, and bioactivity throughout the process.
Click to read the full article.

This SOP outlines the process for incorporating amino acids into lyophilized formulations, ensuring that the amino acids function as stabilizers or cryoprotectants while maintaining product integrity and stability.
Click to read the full article.

This SOP outlines the procedure for preparing lyophilized formulations that are intended to be reconstituted with a diluent before administration, ensuring the product remains stable, safe, and effective upon reconstitution.
Click to read the full article.

This SOP outlines the process for incorporating antioxidants into lyophilized formulations to prevent oxidative degradation of the active ingredients during processing and storage.
Click to read the full article.

This SOP outlines the procedure for preparing antibiotics for freeze-drying (lyophilization), ensuring product sterility and stability throughout the process and during storage.
Click to read the full article.

This SOP outlines the procedure for incorporating chelating agents into lyophilized products to stabilize metal-sensitive active ingredients by binding metal ions that could lead to degradation.
Click to read the full article.

This SOP describes the process of preparing lyophilized formulations intended for intravenous (IV) administration, ensuring sterility, stability, and proper reconstitution characteristics.
Click to read the full article.